Adial Pharmaceuticals, Inc.
Support and Resistance Levels
Past performance
News About ADIL
All events for ADIL
All deals for ADIL
Financial Ratios
Financial Statements
ADIL vs Sector & Peers
About Adial Pharmaceuticals, Inc.
Adial Pharmaceuticals, Inc. is a biopharmaceutical enterprise operating at the clinical stage, dedicated to researching and developing innovative therapeutic options for the management and prevention of addiction and associated disorders. Its primary investigational compound, AD04, functions as a selective serotonin-3 antagonist and is currently undergoing pivotal Phase III clinical trials for the treatment of alcohol use disorder. Beyond this flagship product, the company is also exploring drug candidates aimed at providing non-opioid pain relief and addressing a range of other medical conditions. Established in 2010, Adial Pharmaceuticals, Inc. is headquartered in Charlottesville, Virginia. Website adial.com
Headquarters Glen Allen, VA, US